Last updated: May 6, 2025
Sponsor: Alexandria University
Overall Status: Active - Recruiting
Phase
2/3
Condition
N/ATreatment
Laparoscopic Transversus Abdominis Plane (LTAP) block
Paragastric neural block
Dexmedetomidine infusion
Clinical Study ID
NCT06970626
16/462
Ages 20-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
American Society of Anesthesiologists (ASA) physical status II- III
BMI 35- 50 kg/m2
Exclusion
Exclusion Criteria:
Significant hepatic, renal, neuromuscular, or cardiac impairments
Extreme obesity (BMI > 50 kg/m2)
Patients on current opioid medication
Allergies to dexmedetomidine or bupivacaine
Study Design
Total Participants: 60
Treatment Group(s): 3
Primary Treatment: Laparoscopic Transversus Abdominis Plane (LTAP) block
Phase: 2/3
Study Start date:
April 03, 2025
Estimated Completion Date:
June 20, 2025
Connect with a study center
Alexandria Main University Hospital
Alexandria,
EgyptActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.